US 7696159
Treatment for basal cell carcinoma
granted A61KA61K31/44A61K47/12
Quick answer
US patent 7696159 (Treatment for basal cell carcinoma) held by Graceway Pharmaceuticals. LLC expires Mon Apr 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Graceway Pharmaceuticals. LLC
- Grant date
- Tue Apr 13 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K31/44, A61K47/12, A61K9/0014, A61P